2016 is proving to be a busy year with significant growth for Lexitas.  We have focused on hiring in a few key areas to support and drive our growth, and Lexitas is very pleased to have added four new team members in the last few months.
Jennifer Daniels joined in May as a Clinical Study Manager.  Jennifer has 16 years of experience in clinical research including 5 years of monitoring and 9 years of managing clinical trials for Quintiles and Parexel prior to joining Lexitas.  She brings a variety of therapeutic experience in global Phase II, III and IV clinical trials.
Chris Matheus joined in June as Executive Director, Business Development.  Chris brings 20 years’ experience managing business development for clinical trial study management technologies.
Siobhan Garbutt joined in July as Associate Director, Clinical Studies.  Siobhan has a Ph.D. in Ophthalmology from University College in London.  She has been involved in clinical research for 14 years with 6 of those managing studies for Alcon.  Siobhan brings with her significant experience in managing phase II III, and IV ophthalmology clinical trials particularly in posterior segment disease.
Mike Schiewe joined in August, as Director of Strategic Programs.  In this role Mike will help clients in unique circumstances find creative solutions to advance products through the drug development process.  Mike brings over 20 years’ experience in clinical research with the vast majority of it being in a variety of ophthalmic indications.